CDC42 and prostate cancer: Primarily, Rho, Cdc42, and Rac proteins are associated with tumorigenesis and cardiovascular disease, including lymphomas, Kaposi’s sarcoma, prostate cancer, gastric cell carcinoma, breast cancer, non-small cell lung cancer, squamous cell carcinoma, and glioblastoma.